AKT1 and gastric cancer: Tian et al. demonstrated that miR-361-5p suppressed autophagy-induced chemoresistance of gastric cancer cells through targeting FOXM1 via the PI3K/Akt/mTOR pathway, providing a potential novel avenue for treatment of gastric cancer [98].